Calcium Dobesilate 500 mg Capsules

Calcium Dobesilate 500 mg Capsules are advanced vasoprotective agents formulated to improve capillary tone, reduce capillary fragility, and promote healthy blood flow. Effectively indicated for the management of chronic venous insufficiency (CVI), varicose veins, edema, and supportive care in diabetic retinopathy. Comes in a secure Alu-Alu blister packaging of 100 capsules (10 strips of 10 capsules each).

Calcium Dobesilate 500 mg Capsules is a pharmaceutical formulation containing Calcium Dobesilate, an active ingredient that acts on the microvascular system and is used to help manage certain conditions associated with impaired circulation and increased permeability of small blood vessels. It is primarily prescribed in selected cases of chronic venous insufficiency, a condition in which the veins have difficulty returning blood efficiently from the legs to the heart, potentially resulting in symptoms such as leg heaviness, discomfort, swelling, and a feeling of tiredness in the lower limbs. Calcium Dobesilate acts on capillary function by helping regulate vascular permeability and supporting microcirculation, which may help reduce excessive fluid leakage from small blood vessels and alleviate certain circulation-related symptoms. Depending on local regulatory approvals and clinical guidance, it may also be used in the management of diabetic retinopathy, a complication of diabetes that affects the small blood vessels of the retina and can threaten vision. Its use in such conditions should be determined by a qualified healthcare professional following an appropriate assessment. The 500 mg capsule strength provides a convenient oral dosage form for administration according to the prescribed treatment regimen. Treatment outcomes depend on the underlying condition, the patient's overall health, and adherence to medical advice; this medicine does not replace the need for blood glucose control in diabetes, appropriate management of venous disease, or regular eye examinations where indicated. Possible adverse effects include nausea, vomiting, diarrhoea, abdominal discomfort, headache, and skin reactions. Although uncommon, serious blood-related adverse effects, including agranulocytosis, have been reported with Calcium Dobesilate. Patients should seek prompt medical attention if they develop unexplained fever, persistent sore throat, mouth ulcers, or other signs of infection during treatment. Caution is particularly important in patients with impaired kidney function, and the healthcare professional should be informed about existing medical conditions and other medicines being taken. Calcium Dobesilate 500 mg Capsules should be used only under appropriate medical supervision, with the dosage and duration determined by the prescribing professional according to the patient's diagnosis and response to treatment.